These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 17520443

  • 1. Fast-disintegrating sublingual epinephrine tablets: effect of tablet dimensions on tablet characteristics.
    Rawas-Qalaji MM, Simons FE, Simons KJ.
    Drug Dev Ind Pharm; 2007 May; 33(5):523-30. PubMed ID: 17520443
    [Abstract] [Full Text] [Related]

  • 2. Fast-disintegrating sublingual tablets: effect of epinephrine load on tablet characteristics.
    Rawas-Qalaji MM, Simons FE, Simons KJ.
    AAPS PharmSciTech; 2006 Apr 28; 7(2):E41. PubMed ID: 16796358
    [Abstract] [Full Text] [Related]

  • 3. Epinephrine for the treatment of anaphylaxis: do all 40 mg sublingual epinephrine tablet formulations with similar in vitro characteristics have the same bioavailability?
    Rawas-Qalaji MM, Simons FE, Simons KJ.
    Biopharm Drug Dispos; 2006 Dec 28; 27(9):427-35. PubMed ID: 17009337
    [Abstract] [Full Text] [Related]

  • 4. Rapidly-disintegrating sublingual tablets of epinephrine: role of non-medicinal ingredients in formulation development.
    Rachid O, Rawas-Qalaji M, Simons FE, Simons KJ.
    Eur J Pharm Biopharm; 2012 Nov 28; 82(3):598-604. PubMed ID: 22683694
    [Abstract] [Full Text] [Related]

  • 5. Formulation and Evaluation of Fast-Disintegrating Sublingual Tablets of Atropine Sulfate: the Effect of Tablet Dimensions and Drug Load on Tablet Characteristics.
    Aodah A, Bafail RS, Rawas-Qalaji M.
    AAPS PharmSciTech; 2017 Jul 28; 18(5):1624-1633. PubMed ID: 27650282
    [Abstract] [Full Text] [Related]

  • 6. Is epinephrine administration by sublingual tablet feasible for the first-aid treatment of anaphylaxis? A proof-of-concept study.
    Gu X, Simons KJ, Simons FE.
    Biopharm Drug Dispos; 2002 Jul 28; 23(5):213-6. PubMed ID: 12116053
    [Abstract] [Full Text] [Related]

  • 7. Comparative Study Between Different Ready-Made Orally Disintegrating Platforms for the Formulation of Sumatriptan Succinate Sublingual Tablets.
    Tayel SA, El Nabarawi MA, Amin MM, AbouGhaly MH.
    AAPS PharmSciTech; 2017 Feb 28; 18(2):410-423. PubMed ID: 27038484
    [Abstract] [Full Text] [Related]

  • 8. Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose equivalence for potential treatment of anaphylaxis.
    Rawas-Qalaji MM, Simons FE, Simons KJ.
    J Allergy Clin Immunol; 2006 Feb 28; 117(2):398-403. PubMed ID: 16461140
    [Abstract] [Full Text] [Related]

  • 9. Effect of the filler grade on the characteristics and the sublingual permeability of atropine sulfate fast disintegrating sublingual tablets.
    Bafail R, Rawas-Qalaji M, Rawas-Qalaji M, Aodah A.
    Drug Dev Ind Pharm; 2019 Oct 28; 45(10):1617-1623. PubMed ID: 31353966
    [Abstract] [Full Text] [Related]

  • 10. Adrenaline (epinephrine) microcrystal sublingual tablet formulation: enhanced absorption in a preclinical model.
    Rawas-Qalaji M, Rachid O, Mendez BA, Losada A, Simons FE, Simons KJ.
    J Pharm Pharmacol; 2015 Jan 28; 67(1):20-5. PubMed ID: 25256073
    [Abstract] [Full Text] [Related]

  • 11. Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets.
    Pabari RM, Ramtoola Z.
    Int J Pharm; 2012 Jul 01; 430(1-2):18-25. PubMed ID: 22465631
    [Abstract] [Full Text] [Related]

  • 12. [Application of β-cyclodextrin in the formulation of ODT tablets containing ibuprofen].
    Zimmer Ł, Kasperek R, Poleszak E.
    Polim Med; 2014 Jul 01; 44(4):231-5. PubMed ID: 25932904
    [Abstract] [Full Text] [Related]

  • 13. In Vivo Evaluation of Taste-Masked Fast-Disintegrating Sublingual Tablets of Epinephrine Microcrystals.
    Rachid O, Simons KJ, Rawas-Qalaji M.
    AAPS PharmSciTech; 2018 Nov 01; 19(8):3886-3894. PubMed ID: 30324360
    [Abstract] [Full Text] [Related]

  • 14. Sublingual Diffusion of Epinephrine Microcrystals from Rapidly Disintegrating Tablets for the Potential First-Aid Treatment of Anaphylaxis: In Vitro and Ex Vivo Study.
    Rawas-Qalaji MM, Werdy S, Rachid O, Simons FE, Simons KJ.
    AAPS PharmSciTech; 2015 Oct 01; 16(5):1203-12. PubMed ID: 25732373
    [Abstract] [Full Text] [Related]

  • 15. Formulation and optimization of orodispersible tablets of diazepam.
    Abed KK, Hussein AA, Ghareeb MM, Abdulrasool AA.
    AAPS PharmSciTech; 2010 Mar 01; 11(1):356-61. PubMed ID: 20232267
    [Abstract] [Full Text] [Related]

  • 16. Formulation of Herbal Fast Disintegrating Tablets and its ex-vivo Study for Anti-histaminic Activity in Guinea Pig Ileum.
    Puri D, Bhandari A, Gaur PK, Yasir M, Kumar SS, Choudhary D, Saxena PK.
    Curr Clin Pharmacol; 2018 Mar 01; 13(2):128-135. PubMed ID: 29521214
    [Abstract] [Full Text] [Related]

  • 17. Development and optimization of a sublingual tablet formulation for physostigmine salicylate.
    Bolourchian N, Hadidi N, Foroutan SM, Shafaghi B.
    Acta Pharm; 2009 Sep 01; 59(3):301-12. PubMed ID: 19819826
    [Abstract] [Full Text] [Related]

  • 18. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S.
    Int J Pharm; 2009 Dec 01; 382(1-2):80-7. PubMed ID: 19686825
    [Abstract] [Full Text] [Related]

  • 19. [Establishment of a Novel Method to Evaluate Water Permeation Rates by Combining the Dynamic Contact Angle and Thermographic Approach: Significance of Disintegration Properties of Orally Disintegrating Tablets].
    Suzuki T, Kurano T, Kanazawa T, Suzuki N.
    Yakugaku Zasshi; 2020 Dec 01; 140(8):1071-1080. PubMed ID: 32741865
    [Abstract] [Full Text] [Related]

  • 20. Soy polysaccharide as a novel superdisintegrant in sildenafil citrate sublingual tablets: preparation, characterization, and in vivo evaluation.
    Hosny KM, Mosli HA, Hassan AH.
    Drug Des Devel Ther; 2015 Dec 01; 9():465-72. PubMed ID: 25624751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.